The biotech exceeded its original IPO target as it awaits a critical regulatory decision that could come early next year.
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
Cambridge biotech raises $192M in upsized IPO ahead of major FDA decision
